@prefix np: <http://www.nanopub.org/nschema#> .
@prefix npx: <http://purl.org/nanopub/x/> .
@prefix orcid: <https://orcid.org/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sub: <http://purl.org/np/RA3WeuDIeL99JaovnsNLJ3-OeGLg6Q5G7VmqyBkCbR_4I#> .
@prefix this: <http://purl.org/np/RA3WeuDIeL99JaovnsNLJ3-OeGLg6Q5G7VmqyBkCbR_4I> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
   rdf:OBJECT rdfs:label "higher than that" .
  rdf:PREDICATE rdfs:label "was" .
  rdf:SUBJECT rdfs:label "The cure rate in the tocilizumab group" .
}
sub:provenance {
   sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4" .
  sub:assertion prov:generatedAtTime "2023-06-13T16:26:23.900301"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0003-4692-1377 .
  rdfs:ABSTRACT-UID rdfs:label "3d1w07zy" .
  rdfs:TRIPLE-UID rdfs:label "3d1w07zy-TRIPLE-ABSTRACT-16" .
}
sub:pubinfo {
   sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "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" ;
    npx:hasSignature "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" ;
    npx:hasSignatureTarget this: .
  this: prov:wasAttributedTo orcid:0000-0003-4692-1377 .
}